To: | Walgreen Co. (ipdocket@walgreens.com) |
Subject: | U.S. Trademark Application Serial No. 88658517 - CONTINUATION OF THERAPY PROGRAM - TM.1046 |
Sent: | January 15, 2020 08:20:17 PM |
Sent As: | ecom101@uspto.gov |
Attachments: | Attachment - 1 Attachment - 2 Attachment - 3 Attachment - 4 Attachment - 5 Attachment - 6 Attachment - 7 Attachment - 8 Attachment - 9 Attachment - 10 Attachment - 11 Attachment - 12 Attachment - 13 Attachment - 14 Attachment - 15 Attachment - 16 Attachment - 17 Attachment - 18 Attachment - 19 Attachment - 20 Attachment - 21 Attachment - 22 Attachment - 23 Attachment - 24 |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88658517
Mark: CONTINUATION OF THERAPY PROGRAM
|
|
Correspondence Address: |
|
Applicant: Walgreen Co.
|
|
Reference/Docket No. TM.1046
Correspondence Email Address: |
|
NONFINAL OFFICE ACTION
The USPTO must receive applicant’s response to this letter within six months of the issue date below or the application will be abandoned. Respond using the Trademark Electronic Application System (TEAS). A link to the appropriate TEAS response form appears at the end of this Office action.
Issue date: January 15, 2020
The referenced application has been reviewed by the assigned trademark examining attorney. Applicant must respond timely and completely to the issue(s) below. 15 U.S.C. §1062(b); 37 C.F.R. §§2.62(a), 2.65(a); TMEP §§711, 718.03.
Search Results
The trademark examining attorney has searched the Office’s database of registered and pending marks and has found no conflicting marks that would bar registration under Trademark Act Section 2(d). TMEP §704.02; see 15 U.S.C. §1052(d).
Refusal To Register—Mark Is Primarily Merely Descriptive
Applicant applies the mark “Continuation of Therapy Program” to retail pharmacy services. The attached evidence shows that the term “continuation of therapy” is commonly used in applicant’s industry to describe an automated refill program for medications. When the mark is applied to applicant’s services, it conveys immediate information about a key feature or characteristic of the services. Therefore, the mark is merely descriptive and cannot proceed to registration on the Principal Register.
In addition to being merely descriptive, the mark appears to be generic; therefore, amendment to the Supplemental Register cannot be suggested.
TEAS PLUS OR TEAS REDUCED FEE (TEAS RF) APPLICANTS – TO MAINTAIN LOWER FEE, ADDITIONAL REQUIREMENTS MUST BE MET, INCLUDING SUBMITTING DOCUMENTS ONLINE: Applicants who filed their application online using the lower-fee TEAS Plus or TEAS RF application form must (1) file certain documents online using TEAS, including responses to Office actions (see TMEP §§819.02(b), 820.02(b) for a complete list of these documents); (2) maintain a valid e-mail correspondence address; and (3) agree to receive correspondence from the USPTO by e-mail throughout the prosecution of the application. See 37 C.F.R. §§2.22(b), 2.23(b); TMEP §§819, 820. TEAS Plus or TEAS RF applicants who do not meet these requirements must submit an additional processing fee of $125 per class of goods and/or services. 37 C.F.R. §§2.6(a)(1)(v), 2.22(c), 2.23(c); TMEP §§819.04, 820.04. However, in certain situations, TEAS Plus or TEAS RF applicants may respond to an Office action by authorizing an examiner’s amendment by telephone or e-mail without incurring this additional fee.
How to respond. Click to file a response to this nonfinal Office action.
/Saima Makhdoom/
Trademark Attorney, USPTO
(571) 272-8802 (Tel)
(571) 273-8802 (Fax)
Saima.Makhdoom@uspto.gov
www.uspto.gov
RESPONSE GUIDANCE